Key facts
- Notable investors include Celesta Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Astranu
- ·The full record, as it builds
Funding rounds
No funding rounds for Astranu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Astranu
Developer of a proprietary technology intended to transform ear diagnostic care. The company's platform uses Optical Coherence Tomography technology to address critical healthcare gaps by helping to reduce incidences of misdiagnosis, unnecessary referrals, and significantly reducing the reliance on costly and invasive exploratory surgery and imaging techniques such as CT and MRI scans, enabling physicians to transform ear diagnostic care through advanced, non-invasive, high-resolution 3D imaging.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- astranu.com/
- Ownership
- Privately Held (backing)
Astranu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Astranu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Astranu in its N-PORT filings yet. We sweep new filings monthly.